| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
56,090,000 |
| Market
Cap: |
33.67(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3858 - $0.62 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for cancer and other serious diseases. Co. utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies (ETBs). Co. is developing ETBs for various targets, including PD-L1, HER2, and CD38. PD-L1 is central to immune checkpoint pathways and is a validated target expressed in a variety of solid tumor cancers. HER2 is clinically validated as a target for the treatment of solid tumors including breast and gastric cancer. CD38 has been validated as a clinical target in the treatment of multiple myeloma.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
250,000 |
250,000 |
4,505,319 |
5,179,319 |
| Total Buy Value |
$587,500 |
$587,500 |
$2,587,500 |
$3,244,937 |
| Total People Bought |
1 |
1 |
1 |
4 |
| Total Buy Transactions |
1 |
1 |
2 |
10 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bb Biotech Ag |
10% Owner |
– – • |
2021-09-21 |
4 |
B |
$6.00 |
$4,500,000 |
D/D |
750,000 |
10,792,003 |
2.45 |
-52% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-09-16 |
4 |
B |
$6.13 |
$613,000 |
D/D |
100,000 |
10,042,003 |
2.45 |
-54% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-07-27 |
4 |
B |
$7.09 |
$531,840 |
D/D |
75,000 |
9,942,003 |
2.45 |
-43% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-07-26 |
4 |
B |
$7.00 |
$559,816 |
D/D |
80,000 |
9,867,003 |
2.45 |
-42% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-07-20 |
4 |
B |
$7.13 |
$891,675 |
D/D |
125,000 |
9,787,003 |
2.45 |
-41% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-07-19 |
4 |
B |
$6.96 |
$830,827 |
D/D |
119,382 |
9,662,003 |
2.45 |
-39% |
|
| Poma Eric E |
See remarks |
• • – |
2021-07-06 |
4 |
OE |
$0.71 |
$2,530 |
D/D |
3,563 |
243,459 |
|
- |
|
| Kim Jason S. |
See remarks |
• – – |
2021-06-28 |
4 |
S |
$8.36 |
$23,157 |
D/D |
(2,770) |
83,404 |
|
28% |
|
| Kim Jason S. |
See remarks |
• – – |
2021-06-28 |
4 |
OE |
$0.71 |
$22,747 |
D/D |
32,038 |
86,174 |
|
- |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-04-19 |
4 |
B |
$8.08 |
$329,941 |
D/D |
40,852 |
9,542,621 |
2.45 |
-22% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-04-15 |
4 |
B |
$8.62 |
$1,292,655 |
D/D |
150,000 |
9,501,769 |
2.45 |
-25% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-04-14 |
4 |
B |
$8.37 |
$1,256,040 |
D/D |
150,000 |
9,351,769 |
2.45 |
-19% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-04-13 |
4 |
B |
$7.81 |
$780,970 |
D/D |
100,000 |
9,201,769 |
2.45 |
-15% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-04-12 |
4 |
B |
$8.02 |
$400,830 |
D/D |
50,000 |
9,101,769 |
2.45 |
-17% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-04-09 |
4 |
B |
$8.23 |
$1,939,633 |
D/D |
235,664 |
9,051,769 |
2.45 |
-18% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-04-08 |
4 |
B |
$8.22 |
$2,466,660 |
D/D |
300,000 |
8,816,105 |
2.45 |
-15% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-04-07 |
4 |
B |
$8.24 |
$1,648,160 |
D/D |
200,000 |
8,516,105 |
2.45 |
-13% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-04-05 |
4 |
B |
$9.44 |
$1,887,100 |
D/D |
200,000 |
8,316,105 |
2.45 |
-27% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-03-29 |
4 |
B |
$11.45 |
$915,848 |
D/D |
80,000 |
8,116,105 |
2.45 |
-38% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-02-24 |
4 |
B |
$11.48 |
$860,835 |
D/D |
75,000 |
8,036,105 |
2.45 |
-34% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-02-23 |
4 |
B |
$11.29 |
$2,653,031 |
D/D |
235,004 |
7,961,105 |
2.45 |
-32% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-02-18 |
4 |
B |
$12.65 |
$14,999,991 |
D/D |
1,185,770 |
7,726,101 |
2.45 |
-37% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-02-01 |
4 |
B |
$11.69 |
$935,344 |
D/D |
80,000 |
6,540,331 |
2.45 |
-25% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2021-01-29 |
4 |
B |
$11.94 |
$955,000 |
D/D |
80,000 |
6,460,331 |
2.45 |
-22% |
|
| Bb Biotech Ag |
10% Owner |
– – • |
2020-12-10 |
4 |
B |
$8.18 |
$2,649,841 |
D/D |
320,000 |
6,380,331 |
2.45 |
3% |
|
48 Records found
|
|
Page 1 of 2 |
|
|
